<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Cell Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Cell Pediatr</journal-id>
<journal-title-group>
<journal-title>Molecular and Cellular Pediatrics</journal-title>
</journal-title-group>
<issn pub-type="epub">2194-7791</issn>
<publisher>
<publisher-name>Springer Berlin Heidelberg</publisher-name>
<publisher-loc>Berlin/Heidelberg</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26869264</article-id>
<article-id pub-id-type="pmc">4751100</article-id>
<article-id pub-id-type="publisher-id">34</article-id>
<article-id pub-id-type="doi">10.1186/s40348-016-0034-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Mini Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mesenchymal stem/stromal cells—a key mediator for regeneration after perinatal morbidity?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5594-0532</contrib-id>
<name>
<surname>Mueller</surname>
<given-names>Martin</given-names>
</name>
<address>
<email>martin.mueller@insel.ch</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wolfs</surname>
<given-names>Tim G. A.</given-names>
</name>
<address>
<email>tim.wolfs@maastrichtuniversity.nl</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
<xref ref-type="aff" rid="Aff4"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schoeberlein</surname>
<given-names>Andreina</given-names>
</name>
<address>
<email>andreina.schoeberlein@dkf.unibe.ch</email>
</address>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gavilanes</surname>
<given-names>Antonio W. D.</given-names>
</name>
<address>
<email>danilo.gavilanes@mumc.nl</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
<xref ref-type="aff" rid="Aff5"></xref>
<xref ref-type="aff" rid="Aff6"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Surbek</surname>
<given-names>Daniel</given-names>
</name>
<address>
<email>daniel.surbek@insel.ch</email>
</address>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kramer</surname>
<given-names>Boris W.</given-names>
</name>
<address>
<email>b.kramer@maastrichtuniversity.nl</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
<xref ref-type="aff" rid="Aff4"></xref>
<xref ref-type="aff" rid="Aff6"></xref>
</contrib>
<aff id="Aff1"><label></label>Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT USA </aff>
<aff id="Aff2"><label></label>Department of Obstetrics and Gynecology, University Hospital Bern and Department of Clinical Research, University of Bern, Bern, Switzerland </aff>
<aff id="Aff3"><label></label>Department of Pediatrics, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands </aff>
<aff id="Aff4"><label></label>School of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands </aff>
<aff id="Aff5"><label></label>Institute of Biomedicine, Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador </aff>
<aff id="Aff6"><label></label>Department of Neuropsychology, Division Neuroscience, School of Mental Health and neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>11</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2016</year>
</pub-date>
<volume>3</volume>
<elocation-id>6</elocation-id>
<history>
<date date-type="received">
<day>9</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>1</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© Mueller et al. 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>Perinatal complications in both term- and preterm-born infants are a leading cause of neonatal morbidities and mortality. Infants face different challenges in the neonatal intensive care unit with long-term morbidities such as perinatal brain injury and bronchopulmonary dysplasia being particularly devastating. While advances in perinatal medicine have improved our understanding of the pathogenesis, effective therapies to prevent and/or reduce the severity of these disorders are still lacking. The potential of mesenchymal stem/stromal cell (MSC) therapy has emerged during the last two decades, and an increasing effort is conducted to address brain- and lung-related morbidities in neonates at risk. Various studies support the notion that MSCs have protective effects. MSCs are an easy source and may be readily available after birth in a clinical setting. MSCs’ mechanisms of action are diverse, including migration and homing, release of growth factors and immunomodulation, and the potential to replace injured cells. Here, we review the pathophysiology of perinatally acquired brain and lung injuries and focus on MSCs as potential candidates for therapeutic strategies summarizing preclinical and clinical evidence.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Perinatal brain injury</kwd>
<kwd>Hypoxic-ischemic encephalopathy</kwd>
<kwd>Bronchopulmonary dysplasia</kwd>
<kwd>Mesenchymal stem cells</kwd>
<kwd>Neonatal</kwd>
<kwd>Perinatal</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p>Despite advances in obstetrics and neonatology, both preterm- and term-born infants continue to face serious risks during pregnancy, parturition, and adaptation after birth. Perinatal medicine is therefore a major public health issue around the world. The clinical presentation after perinatal complications or preterm birth in an individual child is complex. This complexity results from multiple potential causal pathways, signs, and symptoms of injury. Typical pathologies in these newborns include perinatal brain injury and bronchopulmonary dysplasia (BPD), among others. New avenues to treat these morbidities have emerged among which stem cells being particularly promising. The body of knowledge of stem cell biology and their function in tissue regeneration and protection has broadened exponentially in the last two decades. This review will discuss mesenchymal stem/stromal cells (MSCs) as a therapeutic approach for both brain and lung diseases in infants at risk. Furthermore, we will highlight the preclinical and clinical data that have emerged on the role of MSCs in perinatal medicine.</p>
</sec>
<sec id="Sec2">
<title>Perinatally acquired organ injury</title>
<p>Perinatally acquired organ injury affects both term and preterm infants. Depending on the timing of injury and/or delivery, infants need to cope with different challenges. In the developing brain of a preterm infant, the spectrum of injury suggests that the underlying pathophysiology is not due to a single lesion but consists of white and gray matter disturbances [<xref ref-type="bibr" rid="CR1">1</xref>]. Thus, a comprehensive multidimensional assessment of potential contributing factors such as maternal medical history, obstetric antecedents, intrapartum factors (including fetal heart rate monitoring results and issues related to the delivery itself), and placental pathology is recommended [<xref ref-type="bibr" rid="CR2">2</xref>]. In the term-born infants, perinatal insults such as birth asphyxia or perinatal stroke affect 1 to 3 newborns out of 1000 [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. In contrast, in preterm-born infants morbidity and mortality strongly relate to the gestational age. While preterm birth before 37 weeks of gestation occurs in 5–8 % of all pregnancies, very low gestational age (VLGA) before 32 weeks of gestation occurs in about 1 % of singletons and 9 % of twin pregnancies [<xref ref-type="bibr" rid="CR5">5</xref>]. Mortality of VLGA infants ranges between 7.3 and 21.4 % at 30 days and 9.0 and 22.7 % at 1 year [<xref ref-type="bibr" rid="CR6">6</xref>]. Additionally, a large number of survivors suffer significant long-term disabilities including cerebral palsy (CP), epilepsy, increased hyperactivity, and developmental disorders [<xref ref-type="bibr" rid="CR7">7</xref>]. For example, the risk to develop CP is 30 times higher in infants born before 33 weeks of gestation compared to term-born infants [<xref ref-type="bibr" rid="CR8">8</xref>]. Moreover, injury in these infants is frequently exacerbated by fetal inflammation and preferentially affects cerebral white matter resulting in periventricular leukomalacia and germinal matrix hemorrhage [<xref ref-type="bibr" rid="CR1">1</xref>]. Currently, the only intervention known to reduce the burden of perinatal brain injury in the term population is hypothermia. Several large clinical trials confirmed that hypothermia in infants with neonatal hypoxic-ischemic encephalopathy is associated with a significant reduction in death and disability [<xref ref-type="bibr" rid="CR9">9</xref>]. However, 40–50 % of infants treated with hypothermia still die or develop significant neurological disability [<xref ref-type="bibr" rid="CR10">10</xref>]. In the preterm population, therapeutic options are lacking as hypothermia is contra-productive. Antenatal magnesium sulfate prior to birth at less than 30 weeks of gestation reduces CP and combined CP and mortality rate at 2 years of age. However, randomized control trials do not demonstrate long-term neurological benefits [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Approximately 25 % of VLGA infants will develop BPD with long-lasting consequences such as chronic respiratory impairment and neurodevelopmental delay [<xref ref-type="bibr" rid="CR13">13</xref>]. Changes in clinical management reduced the incidence of BPD significantly with a shift from VLGA to extreme low gestational age newborns developing BPD. Not surprisingly, the current pathogenesis of BPD is based on immaturity with disordered alveolar and capillary development and represents a developmental disorder [<xref ref-type="bibr" rid="CR14">14</xref>]. The plasticity of the developing lung after preterm birth is poorly understood. Long-term follow-up studies suggest an incomplete regeneration of the lung growth in survivors with BPD. Current treatment options for BPD include vitamin A and caffeine in addition to supportive therapies, but their results often remain unsatisfactory [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
<p>Together, therapeutic approaches to counteract the consequences of perinatally acquired injury are sparse, and new measures are desperately needed especially for preterm infants [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref>].</p>
</sec>
<sec id="Sec3">
<title>Pathophysiology of brain and lung injury</title>
<p>Experimental studies identified different phases of perinatally induced neuronal death. Primary neuronal death is related to depletion of tissue energy reserves with primary energy failure. The secondary and tertiary phases are related to excitotoxicity, mitochondrial dysfunction, and free radical accumulation leading to cell necrosis or apoptosis with impaired myelination and/or axonal function [<xref ref-type="bibr" rid="CR18">18</xref>]. The secondary and tertiary phases may cause persistent inflammation and gliosis, sensitization to further injury, and impaired oligodendrocyte maturation and myelination [<xref ref-type="bibr" rid="CR19">19</xref>]. Interestingly, inflammation is increasingly recognized as being a critical contributor to both normal development and injury outcome especially in the immature brain [<xref ref-type="bibr" rid="CR20">20</xref>]. Maternal infection/inflammation is not only a major risk for preterm birth but is linked to systemic fetal inflammatory response which, in turn, may elicit injury in the fetus. Perinatal inflammation modulates vulnerability to and development of brain injury [<xref ref-type="bibr" rid="CR21">21</xref>] and influences critical phases of myelination and cortical plasticity [<xref ref-type="bibr" rid="CR20">20</xref>]. Several studies suggest that inflammation may play a critical role in autism and schizophrenia [<xref ref-type="bibr" rid="CR22">22</xref>]. Together, brain development, myelination, vascularization, and apoptosis are strongly influenced by inflammatory responses in both physiologic and pathophysiologic conditions [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Pivotal regulators of inflammatory responses in the brain are glial cells which orchestrate the release of pro- and anti-inflammatory cytokines [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α and interferon gamma (IFN-γ) are cytotoxic to oligodendrocytes [<xref ref-type="bibr" rid="CR26">26</xref>]. However, glial cells may produce anti-inflammatory cytokines (e.g., IL-10), which suppress expansion of IL-1β and TNF-α and contribute to resolving inflammation and repair processes [<xref ref-type="bibr" rid="CR25">25</xref>]. Further, astrogliotic scar formation installs a barrier around tissue lesions to restrict the crossing of inflammatory cells into surrounding healthy areas [<xref ref-type="bibr" rid="CR24">24</xref>].</p>
<p>The regulation of the inflammatory responses in the newborn appears to be a link that may explain some of the common features of organ injury in preterm infants. Many studies identified characteristic inflammatory changes and altered growth factor signaling in BPD such as initial influx of neutrophils into the lung followed by increased numbers of macrophages [<xref ref-type="bibr" rid="CR27">27</xref>]. The release of cytokines and disturbance of growth factor signaling such as transforming growth factor (TGF)-β results in increased apoptotic process [<xref ref-type="bibr" rid="CR28">28</xref>]. Furthermore, several studies showed that dysmorphic capillaries and subsequent development of pulmonary hypertension are related to an altered pattern of angiogenic growth factors such as vascular endothelial growth factor (VEGF) and its receptors [<xref ref-type="bibr" rid="CR29">29</xref>]. Finally, lung injury leads to remodeling or early alveolar epithelial dysfunction which in turn promotes lung inflammation [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
<p>Taken together, perinatal inflammation is a strong modulator of both physiologic and pathophysiologic development of the neonatal organs. The fetal inflammatory response to certain cues such as lipopolysaccharides (LPS) [<xref ref-type="bibr" rid="CR31">31</xref>] can be detected not only in the brain and the lung but also in remote tissues not directly exposed to LPS such as the spleen, liver, and mediastinal lymph nodes [<xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR34">34</xref>]. Protective strategies to counteract the cascades leading to injury should therefore not focus on one organ or system but rather treat perinatally acquired injury globally, in which the immune system plays a key role. MSCs possess a regenerative potential. They were shown to modulate innate and adaptive immune responses, to have antiapoptotic effects, to decrease inflammation, and to enhance tissue repair, mostly through the release of paracrine factors [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>].</p>
</sec>
<sec id="Sec4">
<title>Mesenchymal stem/stromal cells</title>
<p>Stem cells are broadly defined as cells with self-renewing and differentiation capacity. Although stem cells derived from embryonic tissue were identified first, the clinical use is limited due to ethical concerns and tumorigenic potential [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Clinical and animal stem cell-based studies to prevent or repair perinatally acquired injury have emerged during the recent years with MSCs being particularly promising. These cells are considered somatic stem cells as they originate from stem cell niches such as bone marrow (BM), skin, adipose umbilical cord, and placental tissues [<xref ref-type="bibr" rid="CR39">39</xref>]. MSCs can be isolated from placental membranes and tissues [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>], amniotic fluid [<xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR44">44</xref>], umbilical cord blood [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], and the umbilical cord connective tissues (Wharton’s jelly; WJ) [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Although all of these cells are MSCs, specific considerations with respect to clinical use, time of application, application route, availability, and ethical aspects need to be made.</p>
<p>MSC-based therapies are an attractive strategy since the pathophysiology of perinatally acquired injury is heterogeneous and MSCs have the capacity to adapt to the microenvironment of injured organs. The strategy may be either or both replacement/restoration of lost tissue and/or protection/salvage of injured cells. In term infants at risk for hypoxic-ischemic injury or neonatal ischemic stroke, MSCs could exert a neuroprotective effect starting at the acute phase of injury. The timing and presentation of the injury are usually well defined. MSCs could provide trophic support and/or amelioration of the inflammatory responses, leading to repair or reduced cell death. However, the different cell types, transplantation routes, and the timing need to be accounted for. Given the gold standard therapy of hypothermia for this kind of injury, MSCs have to proof additive/synergistic effects in order to be considered [<xref ref-type="bibr" rid="CR49">49</xref>]. In contrast, in the preterm population, the timing of the injury is often unclear and the pathophysiology is more complex. The clinical diagnosis of infants at risk is challenging as symptoms such as CP or BPD are diagnosed in early childhood years. Thus, the injury may be considered more chronic as extensive atrophy and gliosis of the white matter tract or dysfunction of lung architecture are present. MSCs could modulate not only the inflammatory response after delivery but also the degree and magnitude of the injured white matter and epithelial cells as well. However, many questions such as altered pattern of growth factors and intercellular matrix proteins that could affect proliferation or differentiation of the desired cell types need to be addressed first.</p>
</sec>
<sec id="Sec5">
<title>MSCs: homing and migration</title>
<p>The approach of MSCs as a therapy for perinatal injury is based on several crucial properties of MSCs, including delivery of the cells “homing” to the site of injury. Migration and homing to the tissue of injury is influenced by multiple factors including age, passage, and number of cells; culture conditions; and delivery method [<xref ref-type="bibr" rid="CR50">50</xref>]. The apparent migration and homing abilities of MSCs without tumorigenic potential were described by several groups and in different disease models [<xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR54">54</xref>]. In BPD animal models, peripherally injected cells were detected in the hyperoxia-induced injured lung [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Experimental studies identified chemokines as major molecules responsible for cell homing with chemokine receptors CXCR3, CXCR4, and CXCR6 being particularly important [<xref ref-type="bibr" rid="CR57">57</xref>–<xref ref-type="bibr" rid="CR59">59</xref>]. Further secretion of factors such as stromal cell-derived factor-1α (SDF-1α), which is a CXCR4 ligand, promotes migration of MSC to the injury site [<xref ref-type="bibr" rid="CR60">60</xref>]. Interestingly, the phenotype of MSCs is an important criterion as well. CD9 (high)-positive MSCs display improved engraftment compared to the CD9 (low)-positive population in a murine ischemic hind limb model [<xref ref-type="bibr" rid="CR61">61</xref>]. This observation highlights the rather heterogeneous MSC population and the importance of proper MSC characterization and definition for future studies. Currently, MSC characterization is based on a set of minimal criteria [<xref ref-type="bibr" rid="CR62">62</xref>], and they display a cell surface repertoire and gene expression pattern which differ among MSCs from various tissues of origin and culture conditions used [<xref ref-type="bibr" rid="CR63">63</xref>–<xref ref-type="bibr" rid="CR66">66</xref>]. For example, MSCs derived from amniotic fluid express many cell surface markers characteristic for BM-derived MSCs including CD73, CD90, CD105, and major histocompatibility complex (MHC) class I [<xref ref-type="bibr" rid="CR44">44</xref>]. The lack of MHC class II, CD40, CD80, and CD86 molecules suggests a low immunogenic phenotype of MSCs when compared to other stem cell sources [<xref ref-type="bibr" rid="CR67">67</xref>]. In contrast, WJ-MSCs express cell surface markers CD29, CD44, CD73, CD90, CD105, CD146, and CD166 [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>] and are considered more primitive cell population relative to BM-derived MSCs [<xref ref-type="bibr" rid="CR70">70</xref>]. As a result, WJ-MSCs differentiate more efficiently into neural progenitors compared to BM-derived MSC [<xref ref-type="bibr" rid="CR71">71</xref>]. In addition, the underlying clinical condition may also affect the phenotype of MSCs. WJ-MSCs derived from umbilical cords collected after preeclamptic pregnancies seem to be more committed to neuroglial differentiation compared to cords from uncomplicated pregnancies [<xref ref-type="bibr" rid="CR66">66</xref>].</p>
</sec>
<sec id="Sec6">
<title>MSCs: secretome and immunomodulation</title>
<p>While MSCs have a proven restorative capacity in response to injury cues, the question of potential protective mechanisms remains unclear. Most of the available data comes from adult neurodegenerative and lung diseases or in vitro studies. Studies identified the induction of cytokines, interleukins, and trophic factors predominately involved in neurogenesis, angiogenesis, hematopoiesis, and cardiovascular regeneration being crucial for the mostly paracrine effects [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. For example, WJ-MSCs’ secretome triggers neuronal survival and differentiation in vitro and in vivo [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Secreted factors such as VEGF-A, angiopoietin-1, fibroblast growth factor (FGF)-I, hepatocyte growth factor (HGF), FGF-II, brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), and platelet-derived growth factor (PDGF)-AB were identified [<xref ref-type="bibr" rid="CR75">75</xref>–<xref ref-type="bibr" rid="CR79">79</xref>]. Importantly, MSCs’ secretome alters both adaptive and innate immune responses [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. MSCs inhibit autoreactive T cell responses in animal models of multiple sclerosis and hypoxic-ischemic brain injury [<xref ref-type="bibr" rid="CR81">81</xref>–<xref ref-type="bibr" rid="CR83">83</xref>]. MSCs shift the alveolar macrophages from a M1 (pro-inflammatory) to a M2 (protective) phenotype ameliorating pulmonary injury in acute LPS-induced acute lung injury model [<xref ref-type="bibr" rid="CR84">84</xref>]. Thus, the shifting from the M1 to the M2 states and promoting regulatory T cells are a function unique to MSCs [<xref ref-type="bibr" rid="CR85">85</xref>]. Besides T cell modulation, MSCs inhibit B cell proliferation, neutrophil and monocyte function, and NK toxicity [<xref ref-type="bibr" rid="CR86">86</xref>–<xref ref-type="bibr" rid="CR89">89</xref>]. Although these modulatory effects are partially understood, direct cell-to-cell contact and soluble factors are relevant [<xref ref-type="bibr" rid="CR90">90</xref>]. Additionally, MSC effects expand beyond constitutive immune modulatory properties with the release of cytokines and growth factors such as VEGF, transforming growth factor beta-1 (TGF-β1), TNF-α, interleukin-1 (IL-1), interleukin-6 (IL-6), and IFN-γ [<xref ref-type="bibr" rid="CR91">91</xref>–<xref ref-type="bibr" rid="CR94">94</xref>].</p>
</sec>
<sec id="Sec7">
<title>MSCs: regeneration/replacement of injured cells</title>
<p>MSCs’ multipotency and self-renewal properties make them valid candidates for providing both lung and brain cell regeneration/replacement. Although, this strategy for repair carries risks such as tumorigenic potential [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>], MSCs were successfully differentiated into various types of cells including cardiomyocytes, myocytes, and epidermal and endothelial cells [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR95">95</xref>–<xref ref-type="bibr" rid="CR97">97</xref>]. Importantly, MSCs express neuroglial commitment and can be differentiated into lung cells as well [<xref ref-type="bibr" rid="CR98">98</xref>–<xref ref-type="bibr" rid="CR102">102</xref>]. Not surprisingly, MSCs are currently tested in various animal models and clinical trials for lung and brain regeneration [<xref ref-type="bibr" rid="CR103">103</xref>–<xref ref-type="bibr" rid="CR105">105</xref>]. Although this line of investigation is particularly intriguing, MSCs’ potential to replace injured cells is not proven and is a matter of constant debate [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]. For example, intravenously injected MSCs improve myocardial infarction without permanent replacement of injured cells [<xref ref-type="bibr" rid="CR107">107</xref>]. In the lung, MSCs embolize causing endothelial damage and are cleared in a matter of hours [<xref ref-type="bibr" rid="CR107">107</xref>]. Taken together, the MSCs’ low rate of in vivo engraftment and differentiation suggests that transplanted cells affect tissue injury and repair through paracrine factors. Whether the factors released by the MSCs or the cells themselves are more promising for the therapy of lung and brain injury in the newborn still remains an open question.</p>
</sec>
<sec id="Sec8">
<title>MSCs: extracellular vehicles</title>
<p>The translation from bench to bedside requires the most efficacious and safest approach. Thus, the question of cell-based versus cell-free therapy needs to be addressed. Given that the MSCs’ therapeutic potential has been shown to be largely triggered via paracrine effects and not differentiation, recent studies focus on extracellular vehicles (EV) [<xref ref-type="bibr" rid="CR108">108</xref>]. These are all types of vehicles present in the extracellular space, including shedding vesicles, apoptotic bodies, and exosomes. Exosomes (40–100 nm in diameter) are secreted by cells in a regulated fashion, possess the ability to transfer proteins and functional genetic materials such as mRNA and microRNAs, and are involved in cell-to-cell signaling and regulation [<xref ref-type="bibr" rid="CR80">80</xref>]. Not surprisingly, MSC-derived EV are contributing to tissue repair in brain injury including stroke and Alzheimer’s disease [<xref ref-type="bibr" rid="CR109">109</xref>–<xref ref-type="bibr" rid="CR111">111</xref>]. The cell-free approach is very promising; however, it is still in its infancy. In fact, stem cells do not just secrete growth factors and/or cytokines but encourage the growth and even supplement (host) cells [<xref ref-type="bibr" rid="CR112">112</xref>–<xref ref-type="bibr" rid="CR114">114</xref>]. Importantly, the stem cells’ potential of immunomodulation and protection after injury seems to depend on the bidirectional communication between the injured host cells and the graft via the exchange of specific information [<xref ref-type="bibr" rid="CR115">115</xref>].</p>
</sec>
<sec id="Sec9">
<title>MSCs: clinical trials</title>
<p>As a result of the remarkable regenerative potential of MSCs, MSCs are ideal candidates for clinical cell therapy. MSCs are easily available, have a good safety profile and homing capacity, and importantly are relatively immunoprivileged, allowing allogeneic transplantation. Not surprisingly, MSCs have been tested in clinical trials in several neurodegenerative diseases such as stroke [<xref ref-type="bibr" rid="CR116">116</xref>–<xref ref-type="bibr" rid="CR118">118</xref>], amyotrophic lateral sclerosis [<xref ref-type="bibr" rid="CR119">119</xref>], multiple sclerosis [<xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR121">121</xref>], and spinal cord injury [<xref ref-type="bibr" rid="CR122">122</xref>]. Several clinical trials indicated no serious side effects or dose-limiting toxicity in acute respiratory distress syndrome [<xref ref-type="bibr" rid="CR123">123</xref>] and chronic obstructive pulmonary disease [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR125">125</xref>]. Also, safety and feasibility trials for CP [<xref ref-type="bibr" rid="CR126">126</xref>–<xref ref-type="bibr" rid="CR128">128</xref>] and BPD [<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>] were successful. A recent double-blind randomized control study used allogeneic umbilical cord blood, in combination with erythropoietin, in children diagnosed with CP showing motor and cognitive benefits [<xref ref-type="bibr" rid="CR131">131</xref>]. In contrast to previous studies, a large safety study used autologous umbilical cord blood directly after birth for infants at risk for hypoxic-ischemic encephalopathy [<xref ref-type="bibr" rid="CR132">132</xref>]. This approach differs significantly from previous studies as it aims mainly to prevent and not to replace affected cells. Cells were transplanted directly after birth and in combination with hypothermia. Authors concluded that the collection, preparation, and infusion of fresh autologous umbilical cord blood cells for use in infants with hypoxic-ischemic encephalopathy are feasible. The feasibility and safety of intra-tracheal infusion of umbilical cord-derived MSCs in BPD was reported as well [<xref ref-type="bibr" rid="CR129">129</xref>]. MSCs reduced BPD severity and retinopathy of prematurity and improved inflammatory cytokine profile in tracheal aspirates in a phase 1 dose escalation study. Several other clinical trials for neonatal brain and lung injury are currently listed as in progress or completed, and more results should become available in the near future (ClinicalTrials.gov Identifiers: NCT01297205, NCT01828957, NCT02023788, NCT01832454, NCT01962233, NCT01988584, NCT01207869).</p>
</sec>
<sec id="Sec10">
<title>Conclusions</title>
<p>Given the array of potential regenerative mechanisms of MSCs to protect neonatal brain and lungs, therapeutic applications can be envisioned in the near future. The mechanisms span anti-apoptotic/pro-mitotic capacities leading to neovascularization by the stimulation of angiogenesis and anti-inflammatory responses. Further, stimulation of neuro- and gliogenesis, synaptogenesis, neurite outgrowth, and also immunomodulation are crucial. Available data clearly demonstrate that MSC and secreted factors are beneficial to treat a variety of neurodegenerative and lung disorders. Although the data are very promising, critical questions need to be answered:<list list-type="bullet"><list-item><p>First, what are the appropriate age, passage, and dosage of the transplanted MSCs? Freshly isolated MSCs may be beneficial compared to cultured cells, but is this practicable in a clinical setting especially in the context of preterm infants [<xref ref-type="bibr" rid="CR133">133</xref>]?</p></list-item><list-item><p>What is the best source and application route of MSCs? Banking of UCB and placental tissue offer an easily accessible and ethically responsible source of MSCs, and minimally invasive routes are currently tested [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR134">134</xref>–<xref ref-type="bibr" rid="CR136">136</xref>].</p></list-item><list-item><p>Finally, how does the transplantation of MSCs impact the standard care in the neonatal intensive care unit? The lack of effective interventions for many morbidities related to prematurity unlocks the potential of cell-based personalized treatments. Safe and effective clinical interventions are future perspectives bearing hope to improve the lifelong outcomes of the infants in our care. This has to be proven in long-term follow-up studies.</p></list-item></list></p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare that they have no competing interests.</p>
</fn>
<fn>
<p>
<bold>Authors’ contributions</bold>
</p>
<p>All authors have made substantive intellectual contributions to this manuscript. MM and BK designed, drafted, and wrote the manuscript. TW, AS, AG, and DS revised and provided critical and important intellectual content. All authors have given final approval of the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>
</fn>
</fn-group>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volpe</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances</article-title>
<source/>Lancet Neurol
          <year>2009</year>
<volume>8</volume>
<issue>1</issue>
<fpage>110</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(08)70294-1</pub-id>
<pub-id pub-id-type="pmid">19081519</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<mixed-citation publication-type="other">Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists' Task Force on Neonatal Encephalopathy (2014). Obstet Gynecol 123 (4):896-901. doi:10.1097/01.AOG.0000445580.65983.d2</mixed-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Ruis</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Hartman</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Northington</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>HE</given-names>
</name>
</person-group>
<article-title>A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy</article-title>
<source/>Am J Obstet Gynecol
          <year>2008</year>
<volume>199</volume>
<issue>6</issue>
<fpage>587</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2008.06.094</pub-id>
<pub-id pub-id-type="pmid">19084096</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cowan</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Mercuri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rutherford</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Perinatal stroke in term infants with neonatal encephalopathy</article-title>
<source/>Neurology
          <year>2005</year>
<volume>64</volume>
<issue>3</issue>
<fpage>579</fpage>
<pub-id pub-id-type="doi">10.1212/WNL.64.3.579-a</pub-id>
<pub-id pub-id-type="pmid">15699409</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaaf</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Mol</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Abu-Hanna</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ravelli</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Trends in preterm birth: singleton and multiple pregnancies in the Netherlands, 2000-2007</article-title>
<source/>BJOG
          <year>2011</year>
<volume>118</volume>
<issue>10</issue>
<fpage>1196</fpage>
<lpage>1204</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-0528.2011.03010.x</pub-id>
<pub-id pub-id-type="pmid">21668771</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numerato</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fattore</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tediosi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zanini</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Peltola</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mihalicza</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lehtonen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Svereus</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heijink</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Klitkou</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Heijden</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lundberg</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Over</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hakkinen</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Seppala</surname>
<given-names>TT</given-names>
</name>
</person-group>
<article-title>Mortality and length of stay of very low birth weight and very preterm infants: a EuroHOPE study</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<issue>6</issue>
<fpage>e0131685</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0131685</pub-id>
<pub-id pub-id-type="pmid">26121647</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Watt</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Yasui</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years</article-title>
<source/>JAMA
          <year>2007</year>
<volume>297</volume>
<issue>24</issue>
<fpage>2733</fpage>
<lpage>2740</lpage>
<pub-id pub-id-type="doi">10.1001/jama.297.24.2733</pub-id>
<pub-id pub-id-type="pmid">17595274</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<mixed-citation publication-type="other">MacLennan AH, Thompson SC, Gecz J (2015) Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol. doi:10.1016/j.ajog.2015.05.034.</mixed-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higgins</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Raju</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Azzopardi</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Bose</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Ferriero</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Guillet</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gunn</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hagberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hirtz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Inder</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Juul</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Laptook</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Lucey</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Maze</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Papile</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pfister</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Rutherford</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shankaran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Silverstein</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Soll</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Thoresen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>WF</given-names>
</name>
</person-group>
<article-title>Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop</article-title>
<source/>J Pediatr
          <year>2011</year>
<volume>159</volume>
<issue>5</issue>
<fpage>851</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2011.08.004</pub-id>
<pub-id pub-id-type="pmid">21875719</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edwards</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Brocklehurst</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gunn</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Halliday</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Juszczak</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Levene</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Strohm</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Thoresen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Whitelaw</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Azzopardi</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data</article-title>
<source/>BMJ
          <year>2010</year>
<volume>340</volume>
<fpage>c363</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.c363</pub-id>
<pub-id pub-id-type="pmid">20144981</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cahill</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Stout</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Caughey</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>Intrapartum magnesium for prevention of cerebral palsy: continuing controversy?</article-title>
<source/>Curr Opin Obstet Gynecol
          <year>2010</year>
<volume>22</volume>
<issue>2</issue>
<fpage>122</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1097/GCO.0b013e3283372312</pub-id>
<pub-id pub-id-type="pmid">20179596</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Doyle LW, Anderson PJ, Haslam R, Lee KJ, Crowther C, Australasian Collaborative Trial of Magnesium Sulphate Study G</collab>
</person-group>
<article-title>School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo</article-title>
<source/>JAMA
          <year>2014</year>
<volume>312</volume>
<issue>11</issue>
<fpage>1105</fpage>
<lpage>1113</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2014.11189</pub-id>
<pub-id pub-id-type="pmid">25226476</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Epidemiology of bronchopulmonary dysplasia</article-title>
<source/>Birth Defects Res A Clin Mol Teratol
          <year>2014</year>
<volume>100</volume>
<issue>3</issue>
<fpage>145</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.23235</pub-id>
<pub-id pub-id-type="pmid">24639412</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Marter</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Epidemiology of bronchopulmonary dysplasia</article-title>
<source/>Semin Fetal Neonatal Med
          <year>2009</year>
<volume>14</volume>
<issue>6</issue>
<fpage>358</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="doi">10.1016/j.siny.2009.08.007</pub-id>
<pub-id pub-id-type="pmid">19783238</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donohue</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Gilmore</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Cristofalo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>JZ</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Inhaled nitric oxide in preterm infants: a systematic review</article-title>
<source/>Pediatrics
          <year>2011</year>
<volume>127</volume>
<issue>2</issue>
<fpage>e414</fpage>
<lpage>e422</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2010-3428</pub-id>
<pub-id pub-id-type="pmid">21220391</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<mixed-citation publication-type="other">Hassell KJ, Ezzati M, Alonso-Alconada D, Hausenloy DJ, Robertson NJ (2015) New horizons for newborn brain protection: enhancing endogenous neuroprotection. Arch Dis Child Fetal Neonatal Ed. doi:10.1136/archdischild-2014-306284.</mixed-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Buonocore</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Turrisi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Balduini</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Perrone</surname>
<given-names>S</given-names>
</name>
</person-group>
<source/>New pharmacological approaches in infants with hypoxic-ischemic encephalopathy
          <year>2012</year>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pleasure</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Soulika</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Gallo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bannerman</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Inflammation in white matter: clinical and pathophysiological aspects</article-title>
<source/>Ment Retard Dev Disabil Res Rev
          <year>2006</year>
<volume>12</volume>
<issue>2</issue>
<fpage>141</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="doi">10.1002/mrdd.20100</pub-id>
<pub-id pub-id-type="pmid">16807906</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Favrais</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van de Looij</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fleiss</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ramanantsoa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bonnin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Stoltenburg-Didinger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lacaud</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saliba</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dammann</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Gallego</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sizonenko</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hagberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lelievre</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gressens</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Systemic inflammation disrupts the developmental program of white matter</article-title>
<source/>Ann Neurol
          <year>2011</year>
<volume>70</volume>
<issue>4</issue>
<fpage>550</fpage>
<lpage>565</lpage>
<pub-id pub-id-type="doi">10.1002/ana.22489</pub-id>
<pub-id pub-id-type="pmid">21796662</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mallard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ferriero</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Vannucci</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Levison</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Vexler</surname>
<given-names>ZS</given-names>
</name>
<name>
<surname>Gressens</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The role of inflammation in perinatal brain injury</article-title>
<source/>Nat Rev Neurol
          <year>2015</year>
<volume>11</volume>
<issue>4</issue>
<fpage>192</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2015.13</pub-id>
<pub-id pub-id-type="pmid">25686754</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eklind</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mallard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leverin</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Gilland</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Blomgren</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mattsby-Baltzer</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hagberg</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury</article-title>
<source/>Eur J Neurosci
          <year>2001</year>
<volume>13</volume>
<issue>6</issue>
<fpage>1101</fpage>
<lpage>1106</lpage>
<pub-id pub-id-type="doi">10.1046/j.0953-816x.2001.01474.x</pub-id>
<pub-id pub-id-type="pmid">11285007</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Feldon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dammann</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?</article-title>
<source/>Pediatr Res
          <year>2011</year>
<volume>69</volume>
<issue>5 Pt 2</issue>
<fpage>26R</fpage>
<lpage>33R</lpage>
<pub-id pub-id-type="doi">10.1203/PDR.0b013e318212c196</pub-id>
<pub-id pub-id-type="pmid">21289540</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shrivastava</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chertoff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Llovera</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Recasens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Acarin</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Short and long-term analysis and comparison of neurodegeneration and inflammatory cell response in the ipsilateral and contralateral hemisphere of the neonatal mouse brain after hypoxia/ischemia</article-title>
<source/>Neurol Res Int
          <year>2012</year>
<volume>2012</volume>
<fpage>781512</fpage>
<pub-id pub-id-type="pmid">22701792</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofroniew</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Astrocyte barriers to neurotoxic inflammation</article-title>
<source/>Nat Rev Neurosci
          <year>2015</year>
<volume>16</volume>
<issue>5</issue>
<fpage>249</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3898</pub-id>
<pub-id pub-id-type="pmid">25891508</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Neher</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Inflammatory neurodegeneration and mechanisms of microglial killing of neurons</article-title>
<source/>Mol Neurobiol
          <year>2010</year>
<volume>41</volume>
<issue>2-3</issue>
<fpage>242</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-010-8105-9</pub-id>
<pub-id pub-id-type="pmid">20195798</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buntinx</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moreels</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vandenabeele</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lambrichts</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Raus</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Steels</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Stinissen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ameloot</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis</article-title>
<source/>J Neurosci Res
          <year>2004</year>
<volume>76</volume>
<issue>6</issue>
<fpage>834</fpage>
<lpage>845</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.20118</pub-id>
<pub-id pub-id-type="pmid">15160395</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Speer</surname>
<given-names>CP</given-names>
</name>
</person-group>
<article-title>Pulmonary inflammation and bronchopulmonary dysplasia</article-title>
<source/>J Perinatol
          <year>2006</year>
<volume>26</volume>
<issue>Suppl 1</issue>
<fpage>S57</fpage>
<lpage>S62</lpage>
<pub-id pub-id-type="doi">10.1038/sj.jp.7211476</pub-id>
<pub-id pub-id-type="pmid">16625227</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunzmann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Speer</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Jobe</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>BW</given-names>
</name>
</person-group>
<article-title>Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs</article-title>
<source/>Am J Physiol Lung Cell Mol Physiol
          <year>2007</year>
<volume>292</volume>
<issue>1</issue>
<fpage>L223</fpage>
<lpage>L231</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00159.2006</pub-id>
<pub-id pub-id-type="pmid">16936247</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thebaud</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity</article-title>
<source/>Neonatology
          <year>2007</year>
<volume>91</volume>
<issue>4</issue>
<fpage>291</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1159/000101344</pub-id>
<pub-id pub-id-type="pmid">17575472</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atochina-Vasserman</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Bates</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Abramova</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>JQ</given-names>
</name>
<name>
<surname>Gochuico</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Gahl</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Gow</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Beers</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Guttentag</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome</article-title>
<source/>Am J Respir Crit Care Med
          <year>2011</year>
<volume>184</volume>
<issue>4</issue>
<fpage>449</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.201011-1882OC</pub-id>
<pub-id pub-id-type="pmid">21616998</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Lopez</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Funderburg</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Cerissi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rifaie</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Aviles-Medina</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Llorens-Bonilla</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Sleasman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Luciano</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Lipopolysaccharide and soluble CD14 in cord blood plasma are associated with prematurity and chorioamnionitis</article-title>
<source/>Pediatr Res
          <year>2014</year>
<volume>75</volume>
<issue>1-1</issue>
<fpage>67</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1038/pr.2013.182</pub-id>
<pub-id pub-id-type="pmid">24135785</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maneenil</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kemp</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Kannan</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Newnham</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Jobe</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Kallapur</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Oral, nasal and pharyngeal exposure to lipopolysaccharide causes a fetal inflammatory response in sheep</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<issue>3</issue>
<fpage>e0119281</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0119281</pub-id>
<pub-id pub-id-type="pmid">25793992</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strackx</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sparnaaij</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Vlassaks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jellema</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kuypers</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Vles</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Gavilanes</surname>
<given-names>AW</given-names>
</name>
</person-group>
<article-title>Lipopolysaccharide-induced chorioamnionitis causes acute inflammatory changes in the ovine central nervous system</article-title>
<source/>CNS Neurol Disord Drug Targets
          <year>2015</year>
<volume>14</volume>
<issue>1</issue>
<fpage>77</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.2174/1871527314666150116120029</pub-id>
<pub-id pub-id-type="pmid">25613498</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuypers</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Jellema</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Kemp</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Newnham</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Delhaas</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kallapur</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Jobe</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Wolfs</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>BW</given-names>
</name>
</person-group>
<article-title>Responses of the spleen to intraamniotic lipopolysaccharide exposure in fetal sheep</article-title>
<source/>Pediatr Res
          <year>2015</year>
<volume>77</volume>
<issue>1-1</issue>
<fpage>29</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1038/pr.2014.152</pub-id>
<pub-id pub-id-type="pmid">25285474</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Krasnodembskaya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Matthay</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors</article-title>
<source/>Stem Cells
          <year>2011</year>
<volume>29</volume>
<issue>6</issue>
<fpage>913</fpage>
<lpage>919</lpage>
<pub-id pub-id-type="doi">10.1002/stem.643</pub-id>
<pub-id pub-id-type="pmid">21506195</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillips</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Fatemi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The potential for cell-based therapy in perinatal brain injuries</article-title>
<source/>Transl Stroke Res
          <year>2013</year>
<volume>4</volume>
<issue>2</issue>
<fpage>137</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1007/s12975-013-0254-5</pub-id>
<pub-id pub-id-type="pmid">23814628</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramalho-Santos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Willenbring</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>On the origin of the term "stem cell"</article-title>
<source/>Cell Stem Cell
          <year>2007</year>
<volume>1</volume>
<issue>1</issue>
<fpage>35</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2007.05.013</pub-id>
<pub-id pub-id-type="pmid">18371332</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caplan</surname>
<given-names>AI</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells</article-title>
<source/>J Orthop Res
          <year>1991</year>
<volume>9</volume>
<issue>5</issue>
<fpage>641</fpage>
<lpage>650</lpage>
<pub-id pub-id-type="doi">10.1002/jor.1100090504</pub-id>
<pub-id pub-id-type="pmid">1870029</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuk</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Futrell</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Benhaim</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Hedrick</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Multilineage cells from human adipose tissue: implications for cell-based therapies</article-title>
<source/>Tissue Eng
          <year>2001</year>
<volume>7</volume>
<issue>2</issue>
<fpage>211</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.1089/107632701300062859</pub-id>
<pub-id pub-id-type="pmid">11304456</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>In 't Anker</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Scherjon</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Kleijburg-van der Keur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>de Groot-Swings</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Claas</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Fibbe</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Kanhai</surname>
<given-names>HH</given-names>
</name>
</person-group>
<article-title>Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta</article-title>
<source/>Stem Cells
          <year>2004</year>
<volume>22</volume>
<issue>7</issue>
<fpage>1338</fpage>
<lpage>1345</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.2004-0058</pub-id>
<pub-id pub-id-type="pmid">15579651</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Igura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mitsuru</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Takashi</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta</article-title>
<source/>Cytotherapy
          <year>2004</year>
<volume>6</volume>
<issue>6</issue>
<fpage>543</fpage>
<lpage>553</lpage>
<pub-id pub-id-type="doi">10.1080/14653240410005366-1</pub-id>
<pub-id pub-id-type="pmid">15770794</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefanidis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Loutradis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Anastasiadou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bletsa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kiapekou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Drakakis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Beretsos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Elenis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mesogitis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Antsaklis</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Oxytocin receptor- and Oct-4-expressing cells in human amniotic fluid</article-title>
<source/>Gynecol Endocrinol
          <year>2008</year>
<volume>24</volume>
<issue>5</issue>
<fpage>280</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="doi">10.1080/09513590801977167</pub-id>
<pub-id pub-id-type="pmid">18569033</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prusa</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Marton</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rosner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bernaschek</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hengstschlager</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?</article-title>
<source/>Hum Reprod
          <year>2003</year>
<volume>18</volume>
<issue>7</issue>
<fpage>1489</fpage>
<lpage>1493</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/deg279</pub-id>
<pub-id pub-id-type="pmid">12832377</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>In 't Anker</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Scherjon</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Kleijburg-van der Keur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Noort</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Claas</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Willemze</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fibbe</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Kanhai</surname>
<given-names>HH</given-names>
</name>
</person-group>
<article-title>Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation</article-title>
<source/>Blood
          <year>2003</year>
<volume>102</volume>
<issue>4</issue>
<fpage>1548</fpage>
<lpage>1549</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2003-04-1291</pub-id>
<pub-id pub-id-type="pmid">12900350</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Harrington</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McNiece</surname>
<given-names>IK</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation</article-title>
<source/>Haematologica
          <year>2004</year>
<volume>89</volume>
<issue>7</issue>
<fpage>837</fpage>
<lpage>844</lpage>
<pub-id pub-id-type="pmid">15257936</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erices</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Conget</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Minguell</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Mesenchymal progenitor cells in human umbilical cord blood</article-title>
<source/>Br J Haematol
          <year>2000</year>
<volume>109</volume>
<issue>1</issue>
<fpage>235</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2141.2000.01986.x</pub-id>
<pub-id pub-id-type="pmid">10848804</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>XW</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>QD</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>TH</given-names>
</name>
</person-group>
<article-title>Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells</article-title>
<source/>Chin Med J (Engl)
          <year>2005</year>
<volume>118</volume>
<issue>23</issue>
<fpage>1987</fpage>
<lpage>1993</lpage>
<pub-id pub-id-type="pmid">16336835</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord</article-title>
<source/>Stem Cells
          <year>2004</year>
<volume>22</volume>
<issue>7</issue>
<fpage>1330</fpage>
<lpage>1337</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.2004-0013</pub-id>
<pub-id pub-id-type="pmid">15579650</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>YS</given-names>
</name>
</person-group>
<article-title>Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<issue>3</issue>
<fpage>e0120893</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0120893</pub-id>
<pub-id pub-id-type="pmid">25816095</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sohni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Verfaillie</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells migration homing and tracking</article-title>
<source/>Stem Cells Int
          <year>2013</year>
<volume>2013</volume>
<fpage>130763</fpage>
<pub-id pub-id-type="doi">10.1155/2013/130763</pub-id>
<pub-id pub-id-type="pmid">24194766</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasad</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Kurtzberg</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Umbilical cord blood transplantation for non-malignant diseases</article-title>
<source/>Bone Marrow Transplant
          <year>2009</year>
<volume>44</volume>
<issue>10</issue>
<fpage>643</fpage>
<lpage>651</lpage>
<pub-id pub-id-type="doi">10.1038/bmt.2009.290</pub-id>
<pub-id pub-id-type="pmid">19802020</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>WZ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Minev</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ichim</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Riordan</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions</article-title>
<source/>J Transl Med
          <year>2010</year>
<volume>8</volume>
<fpage>75</fpage>
<pub-id pub-id-type="doi">10.1186/1479-5876-8-75</pub-id>
<pub-id pub-id-type="pmid">20682053</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schoeberlein</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reinhart</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Sager</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Messerli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Surbek</surname>
<given-names>DV</given-names>
</name>
</person-group>
<article-title>Homing of placenta-derived mesenchymal stem cells after perinatal intracerebral transplantation in a rat model</article-title>
<source/>Am J Obstet Gynecol
          <year>2011</year>
<volume>205</volume>
<issue>3</issue>
<fpage>277</fpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2011.06.044</pub-id>
<pub-id pub-id-type="pmid">22071064</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Coppi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bartsch</surname>
<given-names>G</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Perin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mostoslavsky</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Serre</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Furth</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Soker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Atala</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Isolation of amniotic stem cell lines with potential for therapy</article-title>
<source/>Nat Biotechnol
          <year>2007</year>
<volume>25</volume>
<issue>1</issue>
<fpage>100</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1274</pub-id>
<pub-id pub-id-type="pmid">17206138</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aslam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baveja</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>OD</given-names>
</name>
<name>
<surname>Fernandez-Gonzalez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mitsialis</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Kourembanas</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease</article-title>
<source/>Am J Respir Crit Care Med
          <year>2009</year>
<volume>180</volume>
<issue>11</issue>
<fpage>1122</fpage>
<lpage>1130</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.200902-0242OC</pub-id>
<pub-id pub-id-type="pmid">19713447</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice</article-title>
<source/>Cell Biol Int
          <year>2012</year>
<volume>36</volume>
<issue>6</issue>
<fpage>589</fpage>
<lpage>594</lpage>
<pub-id pub-id-type="doi">10.1042/CBI20110447</pub-id>
<pub-id pub-id-type="pmid">22339670</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaerve</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>HW</given-names>
</name>
</person-group>
<article-title>Chemokines in CNS injury and repair</article-title>
<source/>Cell Tissue Res
          <year>2012</year>
<volume>349</volume>
<issue>1</issue>
<fpage>229</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-012-1427-3</pub-id>
<pub-id pub-id-type="pmid">22700007</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>QA</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>ZG</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>ZM</given-names>
</name>
</person-group>
<article-title>Common expression of stemness molecular markers and early cardiac transcription factors in human Wharton's jelly-derived mesenchymal stem cells and embryonic stem cells</article-title>
<source/>Cell Transplant
          <year>2013</year>
<volume>22</volume>
<issue>10</issue>
<fpage>1883</fpage>
<lpage>1900</lpage>
<pub-id pub-id-type="doi">10.3727/096368912X662444</pub-id>
<pub-id pub-id-type="pmid">23394400</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>JX</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>QP</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>QP</given-names>
</name>
</person-group>
<article-title>CXCR4 receptor overexpression in mesenchymal stem cells facilitates treatment of acute lung injury in rats</article-title>
<source/>J Biol Chem
          <year>2015</year>
<volume>290</volume>
<issue>4</issue>
<fpage>1994</fpage>
<lpage>2006</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M114.605063</pub-id>
<pub-id pub-id-type="pmid">25492872</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Sheu</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Yiin</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Sheehan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>HC</given-names>
</name>
</person-group>
<article-title>Dual regeneration of muscle and nerve by intravenous administration of human amniotic fluid-derived mesenchymal stem cells regulated by stromal cell-derived factor-1alpha in a sciatic nerve injury model</article-title>
<source/>J Neurosurg
          <year>2012</year>
<volume>116</volume>
<issue>6</issue>
<fpage>1357</fpage>
<lpage>1367</lpage>
<pub-id pub-id-type="doi">10.3171/2012.2.JNS111360</pub-id>
<pub-id pub-id-type="pmid">22503125</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Role of CD9 in proliferation and proangiogenic action of human adipose-derived mesenchymal stem cells</article-title>
<source/>Pflugers Arch
          <year>2007</year>
<volume>455</volume>
<issue>2</issue>
<fpage>283</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1007/s00424-007-0285-4</pub-id>
<pub-id pub-id-type="pmid">17668233</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominici</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Le Blanc</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Slaper-Cortenbach</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Marini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Krause</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Deans</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Keating</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Prockop</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Horwitz</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement</article-title>
<source/>Cytotherapy
          <year>2006</year>
<volume>8</volume>
<issue>4</issue>
<fpage>315</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1080/14653240600855905</pub-id>
<pub-id pub-id-type="pmid">16923606</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roobrouck</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Vanuytsel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Verfaillie</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Concise review: culture mediated changes in fate and/or potency of stem cells</article-title>
<source/>Stem Cells
          <year>2011</year>
<volume>29</volume>
<issue>4</issue>
<fpage>583</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="doi">10.1002/stem.603</pub-id>
<pub-id pub-id-type="pmid">21305670</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brooke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Levesque</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta</article-title>
<source/>Stem Cells Dev
          <year>2008</year>
<volume>17</volume>
<issue>5</issue>
<fpage>929</fpage>
<lpage>940</lpage>
<pub-id pub-id-type="doi">10.1089/scd.2007.0156</pub-id>
<pub-id pub-id-type="pmid">18564033</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariotti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mirabelli</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Abate</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schiattarella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fortunato</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Di Noto</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Del Vecchio</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Comparative characteristics of mesenchymal stem cells from human bone marrow and placenta: CD10, CD49d, and CD56 make a difference</article-title>
<source/>Stem Cells Dev
          <year>2008</year>
<volume>17</volume>
<issue>6</issue>
<fpage>1039</fpage>
<lpage>1041</lpage>
<pub-id pub-id-type="doi">10.1089/scd.2008.0212</pub-id>
<pub-id pub-id-type="pmid">18713024</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joerger-Messerli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bruhlmann</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bessire</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Surbek</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Schoeberlein</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Preeclampsia enhances neuroglial marker expression in umbilical cord Wharton's jelly-derived mesenchymal stem cells</article-title>
<source/>J Matern Fetal Neonatal Med
          <year>2015</year>
<volume>28</volume>
<issue>4</issue>
<fpage>464</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="doi">10.3109/14767058.2014.921671</pub-id>
<pub-id pub-id-type="pmid">24803009</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moorefield</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>McKee</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Solchaga</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Orlando</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Furth</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>CE</given-names>
</name>
</person-group>
<article-title>Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<issue>10</issue>
<fpage>e26535</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0026535</pub-id>
<pub-id pub-id-type="pmid">22046303</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fong</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Chak</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Gauthaman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>WK</given-names>
</name>
<name>
<surname>Bongso</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells</article-title>
<source/>Stem Cell Rev
          <year>2011</year>
<volume>7</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1007/s12015-010-9166-x</pub-id>
<pub-id pub-id-type="pmid">20602182</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bongso</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Comparative characterization of cells from the various compartments of the human umbilical cord shows that the Wharton's jelly compartment provides the best source of clinically utilizable mesenchymal stem cells</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<issue>6</issue>
<fpage>e0127992</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0127992</pub-id>
<pub-id pub-id-type="pmid">26061052</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troyer</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Wharton's jelly-derived cells are a primitive stromal cell population</article-title>
<source/>Stem Cells
          <year>2008</year>
<volume>26</volume>
<issue>3</issue>
<fpage>591</fpage>
<lpage>599</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.2007-0439</pub-id>
<pub-id pub-id-type="pmid">18065397</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balasubramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thej</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Venugopal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Priya</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zakaria</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sundarraj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Majumdar</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow</article-title>
<source/>Cell Biol Int
          <year>2013</year>
<volume>37</volume>
<issue>5</issue>
<fpage>507</fpage>
<lpage>515</lpage>
<pub-id pub-id-type="doi">10.1002/cbin.10056</pub-id>
<pub-id pub-id-type="pmid">23418097</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<issue>8</issue>
<fpage>e72604</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0072604</pub-id>
<pub-id pub-id-type="pmid">23991127</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pires</surname>
<given-names>AO</given-names>
</name>
<name>
<surname>Neves-Carvalho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Salgado</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>The secretome of bone marrow and Wharton jelly derived mesenchymal stem cells induces differentiation and neurite outgrowth in SH-SY5Y cells</article-title>
<source/>Stem Cells Int
          <year>2014</year>
<volume>2014</volume>
<fpage>438352</fpage>
<pub-id pub-id-type="doi">10.1155/2014/438352</pub-id>
<pub-id pub-id-type="pmid">25132857</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Neves-Carvalho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Panchalingam</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Behie</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Salgado</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation</article-title>
<source/>Stem Cell Rev
          <year>2015</year>
<volume>11</volume>
<issue>2</issue>
<fpage>288</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1007/s12015-014-9576-2</pub-id>
<pub-id pub-id-type="pmid">25420577</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Constantin</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Marconi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Angiari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Calderan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anghileri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gini</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bach</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Martinello</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bifari</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Galie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Turano</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Budui</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sbarbati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Krampera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bonetti</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis</article-title>
<source/>Stem Cells
          <year>2009</year>
<volume>27</volume>
<issue>10</issue>
<fpage>2624</fpage>
<lpage>2635</lpage>
<pub-id pub-id-type="doi">10.1002/stem.194</pub-id>
<pub-id pub-id-type="pmid">19676124</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Caplan</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>DeChant</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hecker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kranso</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zaremba</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models</article-title>
<source/>Nat Neurosci
          <year>2012</year>
<volume>15</volume>
<issue>6</issue>
<fpage>862</fpage>
<lpage>870</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3109</pub-id>
<pub-id pub-id-type="pmid">22610068</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voulgari-Kokota</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fairless</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Karamita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kyrargyri</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tseveleki</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Evangelidou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Charbord</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Diem</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Probert</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function</article-title>
<source/>Exp Neurol
          <year>2012</year>
<volume>236</volume>
<issue>1</issue>
<fpage>161</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2012.04.011</pub-id>
<pub-id pub-id-type="pmid">22561409</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord</article-title>
<source/>Neuropathology
          <year>2010</year>
<volume>30</volume>
<issue>3</issue>
<fpage>205</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1789.2009.01063.x</pub-id>
<pub-id pub-id-type="pmid">19845866</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Meliton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moldobaeva</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mutlu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Akiyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Birukova</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction</article-title>
<source/>Am J Physiol Lung Cell Mol Physiol
          <year>2015</year>
<volume>308</volume>
<issue>5</issue>
<fpage>L452</fpage>
<lpage>L463</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00170.2014</pub-id>
<pub-id pub-id-type="pmid">25539852</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<mixed-citation publication-type="other">Bruno S, Deregibus MC, Camussi G (2015) The secretome of mesenchymal stromal cells: role of extracellular vesicles in immunomodulation. Immunol Lett. doi:10.1016/j.imlet.2015.06.007</mixed-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerdoni</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gallo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Casazza</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Musio</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bonanni</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pedemonte</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mantegazza</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Frassoni</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mancardi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pedotti</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Uccelli</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis</article-title>
<source/>Ann Neurol
          <year>2007</year>
<volume>61</volume>
<issue>3</issue>
<fpage>219</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21076</pub-id>
<pub-id pub-id-type="pmid">17387730</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jellema</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Wolfs</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Lima Passos</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zwanenburg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ophelders</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Kuypers</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hopman</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Dudink</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Steinbusch</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Andriessen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Germeraad</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Vanderlocht</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>BW</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<issue>8</issue>
<fpage>e73031</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0073031</pub-id>
<pub-id pub-id-type="pmid">23991170</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duffy</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ritter</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ceredig</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cell effects on T-cell effector pathways</article-title>
<source/>Stem Cell Res Ther
          <year>2011</year>
<volume>2</volume>
<issue>4</issue>
<fpage>34</fpage>
<pub-id pub-id-type="doi">10.1186/scrt75</pub-id>
<pub-id pub-id-type="pmid">21861858</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maron-Gutierrez</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Asensi</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Bakker-Abreu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Goldenberg</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Rocco</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Dos Santos</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice</article-title>
<source/>Crit Care Med
          <year>2013</year>
<volume>41</volume>
<issue>11</issue>
<fpage>e319</fpage>
<lpage>e333</lpage>
<pub-id pub-id-type="doi">10.1097/CCM.0b013e31828a663e</pub-id>
<pub-id pub-id-type="pmid">23760104</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Nicola</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carlo-Stella</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Magni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Milanesi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Longoni</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Matteucci</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Grisanti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gianni</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli</article-title>
<source/>Blood
          <year>2002</year>
<volume>99</volume>
<issue>10</issue>
<fpage>3838</fpage>
<lpage>3843</lpage>
<pub-id pub-id-type="doi">10.1182/blood.V99.10.3838</pub-id>
<pub-id pub-id-type="pmid">11986244</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franquesa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hoogduijn</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Bestard</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Grinyo</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Immunomodulatory effect of mesenchymal stem cells on B cells</article-title>
<source/>Front Immunol
          <year>2012</year>
<volume>3</volume>
<fpage>212</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2012.00212</pub-id>
<pub-id pub-id-type="pmid">22833744</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raffaghello</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bertolotto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Montecucco</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Busca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dallegri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ottonello</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pistoia</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche</article-title>
<source/>Stem Cells
          <year>2008</year>
<volume>26</volume>
<issue>1</issue>
<fpage>151</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1634/stemcells.2007-0416</pub-id>
<pub-id pub-id-type="pmid">17932421</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanova-Todorova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bochev</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mourdjeva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dimitrov</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bukarev</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kyurkchiev</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tivchev</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Altunkova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kyurkchiev</surname>
<given-names>DS</given-names>
</name>
</person-group>
<article-title>Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells</article-title>
<source/>Immunol Lett
          <year>2009</year>
<volume>126</volume>
<issue>1-2</issue>
<fpage>37</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.imlet.2009.07.010</pub-id>
<pub-id pub-id-type="pmid">19647021</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spaggiari</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Capobianco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abdelrazik</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Becchetti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mingari</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Moretta</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2</article-title>
<source/>Blood
          <year>2008</year>
<volume>111</volume>
<issue>3</issue>
<fpage>1327</fpage>
<lpage>1333</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2007-02-074997</pub-id>
<pub-id pub-id-type="pmid">17951526</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahmat</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Jose</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ramasamy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vidyadaran</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Reciprocal interactions of mouse bone marrow-derived mesenchymal stem cells and BV2 microglia after lipopolysaccharide stimulation</article-title>
<source/>Stem Cell Res Ther
          <year>2013</year>
<volume>4</volume>
<issue>1</issue>
<fpage>12</fpage>
<pub-id pub-id-type="doi">10.1186/scrt160</pub-id>
<pub-id pub-id-type="pmid">23356521</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasanna</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Gopalakrishnan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Vasandan</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially</article-title>
<source/>PLoS ONE
          <year>2010</year>
<volume>5</volume>
<issue>2</issue>
<fpage>e9016</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0009016</pub-id>
<pub-id pub-id-type="pmid">20126406</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>WI</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury</article-title>
<source/>Am J Respir Cell Mol Biol
          <year>2014</year>
<volume>51</volume>
<issue>3</issue>
<fpage>391</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="doi">10.1165/rcmb.2013-0385OC</pub-id>
<pub-id pub-id-type="pmid">24669883</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guan</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>ZL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>WG</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors</article-title>
<source/>J Cell Biochem
          <year>2013</year>
<volume>114</volume>
<issue>2</issue>
<fpage>323</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.24377</pub-id>
<pub-id pub-id-type="pmid">22949406</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aggarwal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pittenger</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Human mesenchymal stem cells modulate allogeneic immune cell responses</article-title>
<source/>Blood
          <year>2005</year>
<volume>105</volume>
<issue>4</issue>
<fpage>1815</fpage>
<lpage>1822</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2004-04-1559</pub-id>
<pub-id pub-id-type="pmid">15494428</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nartprayut</surname>
<given-names>K</given-names>
</name>
<name>
<surname>U-Pratya</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kheolamai</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Manochantr</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chayosumrit</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Issaragrisil</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Supokawej</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Cardiomyocyte differentiation of perinatally derived mesenchymal stem cells</article-title>
<source/>Mol Med Rep
          <year>2013</year>
<volume>7</volume>
<issue>5</issue>
<fpage>1465</fpage>
<lpage>1469</lpage>
<pub-id pub-id-type="pmid">23467912</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Human umbilical cord-derived mesenchymal stem cells differentiate into epidermal-like cells using a novel co-culture technique</article-title>
<source/>Cytotechnology
          <year>2014</year>
<volume>66</volume>
<issue>4</issue>
<fpage>699</fpage>
<lpage>708</lpage>
<pub-id pub-id-type="doi">10.1007/s10616-013-9569-z</pub-id>
<pub-id pub-id-type="pmid">24952026</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>ZC</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>YL</given-names>
</name>
</person-group>
<article-title>In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells</article-title>
<source/>J Cell Biochem
          <year>2007</year>
<volume>100</volume>
<issue>3</issue>
<fpage>608</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.21078</pub-id>
<pub-id pub-id-type="pmid">16960877</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leite</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Mendes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Faria</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Lourenco</surname>
<given-names>T</given-names>
</name>
<name>
<surname>dos Santos</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>PZ</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Paiva</surname>
<given-names>A</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Cabral</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Relvas</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Graos</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Differentiation of human umbilical cord matrix mesenchymal stem cells into neural-like progenitor cells and maturation into an oligodendroglial-like lineage</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<issue>10</issue>
<fpage>e111059</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0111059</pub-id>
<pub-id pub-id-type="pmid">25357129</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>RX</given-names>
</name>
</person-group>
<article-title>Comparison of the neural differentiation potential of human mesenchymal stem cells from amniotic fluid and adult bone marrow</article-title>
<source/>Cell Mol Neurobiol
          <year>2013</year>
<volume>33</volume>
<issue>4</issue>
<fpage>465</fpage>
<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1007/s10571-013-9922-y</pub-id>
<pub-id pub-id-type="pmid">23478940</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendez</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Ghaedi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Steinbacher</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Niklason</surname>
<given-names>LE</given-names>
</name>
</person-group>
<article-title>Epithelial cell differentiation of human mesenchymal stromal cells in decellularized lung scaffolds</article-title>
<source/>Tissue Eng Part A
          <year>2014</year>
<volume>20</volume>
<issue>11-12</issue>
<fpage>1735</fpage>
<lpage>1746</lpage>
<pub-id pub-id-type="doi">10.1089/ten.tea.2013.0647</pub-id>
<pub-id pub-id-type="pmid">24393055</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats</article-title>
<source/>Mol Med Rep
          <year>2015</year>
<volume>11</volume>
<issue>3</issue>
<fpage>1685</fpage>
<lpage>1692</lpage>
<pub-id pub-id-type="pmid">25411925</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerrada</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de la Torre</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Grande</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Perez-Gil</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Human decidua-derived mesenchymal stem cells differentiate into functional alveolar type II-like cells that synthesize and secrete pulmonary surfactant complexes</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<issue>10</issue>
<fpage>e110195</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0110195</pub-id>
<pub-id pub-id-type="pmid">25333871</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotton</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Morrisey</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Lung regeneration: mechanisms, applications and emerging stem cell populations</article-title>
<source/>Nat Med
          <year>2014</year>
<volume>20</volume>
<issue>8</issue>
<fpage>822</fpage>
<lpage>832</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3642</pub-id>
<pub-id pub-id-type="pmid">25100528</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uccelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Benvenuto</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Laroni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giunti</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Neuroprotective features of mesenchymal stem cells</article-title>
<source/>Best Pract Res Clin Haematol
          <year>2011</year>
<volume>24</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/j.beha.2011.01.004</pub-id>
<pub-id pub-id-type="pmid">21396593</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stabler</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Lecht</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lazarovici</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lelkes</surname>
<given-names>PI</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells for therapeutic applications in pulmonary medicine</article-title>
<source/>Br Med Bull
          <year>2015</year>
<pub-id pub-id-type="pmid">26063231</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianco</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Frenette</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Robey</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CY</given-names>
</name>
</person-group>
<article-title>The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine</article-title>
<source/>Nat Med
          <year>2013</year>
<volume>19</volume>
<issue>1</issue>
<fpage>35</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3028</pub-id>
<pub-id pub-id-type="pmid">23296015</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Pulin</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kota</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Ylostalo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Semprun-Prieto</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Delafontaine</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Prockop</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6</article-title>
<source/>Cell Stem Cell
          <year>2009</year>
<volume>5</volume>
<issue>1</issue>
<fpage>54</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2009.05.003</pub-id>
<pub-id pub-id-type="pmid">19570514</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katsuda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kosaka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takeshita</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ochiya</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles</article-title>
<source/>Proteomics
          <year>2013</year>
<volume>13</volume>
<issue>10-11</issue>
<fpage>1637</fpage>
<lpage>1653</lpage>
<pub-id pub-id-type="doi">10.1002/pmic.201200373</pub-id>
<pub-id pub-id-type="pmid">23335344</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Buller</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Katakowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>ZG</given-names>
</name>
<name>
<surname>Chopp</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth</article-title>
<source/>Stem Cells
          <year>2012</year>
<volume>30</volume>
<issue>7</issue>
<fpage>1556</fpage>
<lpage>1564</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1129</pub-id>
<pub-id pub-id-type="pmid">22605481</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dreyer</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>New insights into the roles of microRNAs in drug addiction and neuroplasticity</article-title>
<source/>Genome Med
          <year>2010</year>
<volume>2</volume>
<issue>12</issue>
<fpage>92</fpage>
<pub-id pub-id-type="doi">10.1186/gm213</pub-id>
<pub-id pub-id-type="pmid">21205279</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katsuda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tsuchiya</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kosaka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yoshioka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Takagaki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Takeshita</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ochiya</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes</article-title>
<source/>Sci Rep
          <year>2013</year>
<volume>3</volume>
<fpage>1197</fpage>
<pub-id pub-id-type="doi">10.1038/srep01197</pub-id>
<pub-id pub-id-type="pmid">23378928</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Fraga</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Graos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Neves</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Gimble</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Salgado</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations</article-title>
<source/>Stem Cell Res Ther
          <year>2012</year>
<volume>3</volume>
<issue>3</issue>
<fpage>18</fpage>
<pub-id pub-id-type="doi">10.1186/scrt109</pub-id>
<pub-id pub-id-type="pmid">22551705</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Salgado</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Fraga</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures)</article-title>
<source/>J Tissue Eng Regen Med
          <year>2011</year>
<volume>5</volume>
<issue>8</issue>
<fpage>668</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="doi">10.1002/term.365</pub-id>
<pub-id pub-id-type="pmid">21774090</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glenn</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Whartenby</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy</article-title>
<source/>World J Stem Cells
          <year>2014</year>
<volume>6</volume>
<issue>5</issue>
<fpage>526</fpage>
<lpage>539</lpage>
<pub-id pub-id-type="doi">10.4252/wjsc.v6.i5.526</pub-id>
<pub-id pub-id-type="pmid">25426250</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pluchino</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cossetti</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>How stem cells speak with host immune cells in inflammatory brain diseases</article-title>
<source/>Glia
          <year>2013</year>
<volume>61</volume>
<issue>9</issue>
<fpage>1379</fpage>
<lpage>1401</lpage>
<pub-id pub-id-type="doi">10.1002/glia.22500</pub-id>
<pub-id pub-id-type="pmid">23633288</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honmou</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Houkin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsunaga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Niitsu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ishiai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Onodera</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Kocsis</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke</article-title>
<source/>Brain
          <year>2011</year>
<volume>134</volume>
<issue>Pt 6</issue>
<fpage>1790</fpage>
<lpage>1807</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awr063</pub-id>
<pub-id pub-id-type="pmid">21493695</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Bang</surname>
<given-names>OY</given-names>
</name>
<collab>collaborators S</collab>
</person-group>
<article-title>A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke</article-title>
<source/>Stem Cells
          <year>2010</year>
<volume>28</volume>
<issue>6</issue>
<fpage>1099</fpage>
<lpage>1106</lpage>
<pub-id pub-id-type="doi">10.1002/stem.430</pub-id>
<pub-id pub-id-type="pmid">20506226</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diez-Tejedor</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gutierrez-Fernandez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martinez-Sanchez</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rodriguez-Frutos</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ruiz-Ares</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lara</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Gimeno</surname>
<given-names>BF</given-names>
</name>
</person-group>
<article-title>Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial</article-title>
<source/>J Stroke Cerebrovasc Dis
          <year>2014</year>
<volume>23</volume>
<issue>10</issue>
<fpage>2694</fpage>
<lpage>2700</lpage>
<pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2014.06.011</pub-id>
<pub-id pub-id-type="pmid">25304723</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazzini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ferrero</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Luparello</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rustichelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gunetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mareschi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Testa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stecco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tarletti</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Miglioretti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fava</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nasuelli</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cisari</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Massara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vercelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Oggioni</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Carriero</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cantello</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fagioli</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial</article-title>
<source/>Exp Neurol
          <year>2010</year>
<volume>223</volume>
<issue>1</issue>
<fpage>229</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2009.08.007</pub-id>
<pub-id pub-id-type="pmid">19682989</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Connick</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kolappan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Webber</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Patani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Michell</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>MQ</given-names>
</name>
<name>
<surname>Luan</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Altmann</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Compston</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Chandran</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study</article-title>
<source/>Lancet Neurol
          <year>2012</year>
<volume>11</volume>
<issue>2</issue>
<fpage>150</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(11)70305-2</pub-id>
<pub-id pub-id-type="pmid">22236384</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llufriu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sepulveda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Blanco</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Marin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Berenguer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gabilondo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Martinez-Heras</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sola-Valls</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Arnaiz</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Andreu</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bullich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sanchez-Dalmau</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Graus</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Villoslada</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Saiz</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<issue>12</issue>
<fpage>e113936</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0113936</pub-id>
<pub-id pub-id-type="pmid">25436769</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Venkataramana</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Bansal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Balaraju</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dixit</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rauthan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Murgod</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Totey</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study</article-title>
<source/>Cytotherapy
          <year>2009</year>
<volume>11</volume>
<issue>7</issue>
<fpage>897</fpage>
<lpage>911</lpage>
<pub-id pub-id-type="doi">10.3109/14653240903253857</pub-id>
<pub-id pub-id-type="pmid">19903102</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study</article-title>
<source/>Respir Res
          <year>2014</year>
<volume>15</volume>
<fpage>39</fpage>
<pub-id pub-id-type="doi">10.1186/1465-9921-15-39</pub-id>
<pub-id pub-id-type="pmid">24708472</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Casaburi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Flannery</surname>
<given-names>R</given-names>
</name>
<name>
<surname>LeRoux-Williams</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tashkin</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>A placebo-controlled, randomized trial of mesenchymal stem cells in COPD</article-title>
<source/>Chest
          <year>2013</year>
<volume>143</volume>
<issue>6</issue>
<fpage>1590</fpage>
<lpage>1598</lpage>
<pub-id pub-id-type="doi">10.1378/chest.12-2094</pub-id>
<pub-id pub-id-type="pmid">23172272</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro-Paes</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Bilaqui</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Greco</surname>
<given-names>OT</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Marcelino</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Stessuk</surname>
<given-names>T</given-names>
</name>
<name>
<surname>de Faria</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Lago</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema</article-title>
<source/>Int J Chron Obstruct Pulmon Dis
          <year>2011</year>
<volume>6</volume>
<fpage>63</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.2147/COPD.S15292</pub-id>
<pub-id pub-id-type="pmid">21311694</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Um</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>YS</given-names>
</name>
</person-group>
<article-title>Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy</article-title>
<source/>J Transl Med
          <year>2012</year>
<volume>10</volume>
<fpage>58</fpage>
<pub-id pub-id-type="doi">10.1186/1479-5876-10-58</pub-id>
<pub-id pub-id-type="pmid">22443810</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mancias-Guerra</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marroquin-Escamilla</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Gonzalez-Llano</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Villarreal-Martinez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jaime-Perez</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Garcia-Rodriguez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Valdes-Burnes</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Rodriguez-Romo</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Barrera-Morales</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Sanchez-Hernandez</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Cantu-Rodriguez</surname>
<given-names>OG</given-names>
</name>
<name>
<surname>Gutierrez-Aguirre</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Gomez-De Leon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Elizondo-Riojas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Salazar-Riojas</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gomez-Almaguer</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial</article-title>
<source/>Cytotherapy
          <year>2014</year>
<volume>16</volume>
<issue>6</issue>
<fpage>810</fpage>
<lpage>820</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcyt.2014.01.008</pub-id>
<pub-id pub-id-type="pmid">24642016</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>An</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study</article-title>
<source/>Cytotherapy
          <year>2013</year>
<volume>15</volume>
<issue>12</issue>
<fpage>1549</fpage>
<lpage>1562</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcyt.2013.06.001</pub-id>
<pub-id pub-id-type="pmid">24100132</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>WI</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial</article-title>
<source/>J Pediatr
          <year>2014</year>
<volume>164</volume>
<issue>5</issue>
<fpage>966</fpage>
<lpage>972</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2013.12.011</pub-id>
<pub-id pub-id-type="pmid">24508444</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pawelec</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gladysz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Demkow</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Boruczkowski</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Stem cell experiments moves into clinic: new hope for children with bronchopulmonary dysplasia</article-title>
<source/>Adv Exp Med Biol
          <year>2015</year>
<volume>839</volume>
<fpage>47</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1007/5584_2014_27</pub-id>
<pub-id pub-id-type="pmid">25252892</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial</article-title>
<source/>Stem Cells
          <year>2013</year>
<volume>31</volume>
<issue>3</issue>
<fpage>581</fpage>
<lpage>591</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1304</pub-id>
<pub-id pub-id-type="pmid">23281216</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotten</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Murtha</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Grotegut</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Gustafson</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Waters-Pick</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Swamy</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Rattray</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kurtzberg</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy</article-title>
<source/>J Pediatr
          <year>2014</year>
<volume>164</volume>
<issue>5</issue>
<fpage>973</fpage>
<lpage>979</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2013.11.036</pub-id>
<pub-id pub-id-type="pmid">24388332</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Ploemacher WJCRaRE</collab>
</person-group>
<article-title>Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture</article-title>
<source/>Leukemia
          <year>2003</year>
<volume>17</volume>
<issue>1</issue>
<fpage>160</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1038/sj.leu.2402763</pub-id>
<pub-id pub-id-type="pmid">12529674</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messerli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sager</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baumann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Surbek</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Schoeberlein</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Stem cells from umbilical cord Wharton's jelly from preterm birth have neuroglial differentiation potential</article-title>
<source/>Reprod Sci
          <year>2013</year>
<volume>20</volume>
<issue>12</issue>
<fpage>1455</fpage>
<lpage>1464</lpage>
<pub-id pub-id-type="doi">10.1177/1933719113488443</pub-id>
<pub-id pub-id-type="pmid">23670950</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<mixed-citation publication-type="other">Donega V, Nijboer CH, van Velthoven CT, Youssef SA, de Bruin A, van Bel F, Kavelaars A, Heijnen CJ (2015) Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse. Pediatric research. doi:10.1038/pr.2015.145</mixed-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mounayar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abdi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fodor</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Padbury</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>De Paepe</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Intranasal versus intraperitoneal delivery of human umbilical cord tissue-derived cultured mesenchymal stromal cells in a murine model of neonatal lung injury</article-title>
<source/>Am J Pathol
          <year>2014</year>
<volume>184</volume>
<issue>12</issue>
<fpage>3344</fpage>
<lpage>3358</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2014.08.010</pub-id>
<pub-id pub-id-type="pmid">25455688</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>